Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › DNA
SUPERSTRING CAPITAL MANAGEMENT LP position in DNA
GINKGO BIOWORKS HOLDINGS INC · Health Care
SUPERSTRING CAPITAL MANAGEMENT LP reported holding 222,553 shares of DNA (GINKGO BIOWORKS HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$2.9M, representing 1.43% of its reported portfolio and ranking #21 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How SUPERSTRING CAPITAL MANAGEMENT LP's DNA position evolved
SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in DNA in Q3 2026 at 222,553 shares (US$2.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 222.55K | $2.86M | New |
About DNA and 13F data
DNA (GINKGO BIOWORKS HOLDINGS INC) is a Health Care company. 33 other funds we track also report a position in DNA — the largest reported positions include Anchorage Capital Group, L.L.C. (US$17.3M), FORBES J M & CO LLP (US$12.5M), SB INVESTMENT ADVISERS (UK) LTD (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DNA
- Anchorage Capital Group, L.L.C. 1.75M sh · $17.31M · Q2 2026
- FORBES J M & CO LLP 977.37K sh · $12.54M · Q3 2026
- SB INVESTMENT ADVISERS (UK) LTD 610.73K sh · $6.05M · Q2 2026
More on SUPERSTRING CAPITAL MANAGEMENT LP
FAQ
How long has SUPERSTRING CAPITAL MANAGEMENT LP held DNA?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed DNA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in DNA?
As of Q3 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 222.55K shares of DNA (GINKGO BIOWORKS HOLDINGS INC), valued at $2.86M, representing 1.43% of its reported portfolio and ranking #21.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling DNA?
In the latest 13F filing (Q3 2026), SUPERSTRING CAPITAL MANAGEMENT LP newly opened its position in DNA.
Which other funds hold DNA?
Other major institutional holders of DNA include Anchorage Capital Group, L.L.C., FORBES J M & CO LLP, SB INVESTMENT ADVISERS (UK) LTD, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.